Carisma Therapeutics, Inc. Common Stock (CARM)
Carisma Therapeutics, Inc. is a biotechnology company focused on developing advanced cell-based immunotherapies, particularly utilizing macrophages to treat cancer and other diseases. Their innovative approach involves engineering immune cells to enhance their ability to target and destroy tumors, with the goal of creating more effective and personalized treatments.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| March 8, 2023 | $0.36 | 2023-03-08 | 2023-03-07 |
Dividends Summary
- Carisma Therapeutics, Inc. Common Stock has issued 1 dividend payments over the past 0 years
- The most recent dividend was paid 959 days ago, on March 8, 2023
- The highest dividend payed out to investors during this period was $0.36 per share
- The average dividend paid during this period was $0.36 per share.
Company News
Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies undergoing mergers or sales transactions.
Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches related to merger and sale transactions involving NV5 Global, Carisma Therapeutics, and Heliogen.
CARISMA THERAP (CARM) delivered earnings and revenue surprises of -24.32% and 12.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?